
Akm E. Ullah
Examiner (ID: 10221, Phone: (571)272-2361 , Office: P/2874 )
| Most Active Art Unit | 2874 |
| Art Unit(s) | 2874, 2606, 2501, 1734, 2899, 3621, 2838 |
| Total Applications | 3400 |
| Issued Applications | 3065 |
| Pending Applications | 95 |
| Abandoned Applications | 245 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18297084
[patent_doc_number] => 20230106770
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => Reagents and methods for preventing, treating or limiting severe acute respiratory syndrome (SARS) coronavirus infection
[patent_app_type] => utility
[patent_app_number] => 17/905315
[patent_app_country] => US
[patent_app_date] => 2021-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12464
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17905315
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/905315 | Reagents and methods for preventing, treating or limiting severe acute respiratory syndrome (SARS) coronavirus infection | Apr 1, 2021 | Pending |
Array
(
[id] => 18349063
[patent_doc_number] => 20230137174
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => NOVEL SALMONELLA-BASED CORONAVIRUS VACCINE
[patent_app_type] => utility
[patent_app_number] => 17/907619
[patent_app_country] => US
[patent_app_date] => 2021-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18631
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17907619
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/907619 | NOVEL SALMONELLA-BASED CORONAVIRUS VACCINE | Mar 30, 2021 | Pending |
Array
(
[id] => 17474176
[patent_doc_number] => 20220081680
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-17
[patent_title] => MATERIALS AND METHODS FOR TREATMENT OF AUTOSOMAL DOMINANT CONE-ROD DYSTROPHY
[patent_app_type] => utility
[patent_app_number] => 17/216303
[patent_app_country] => US
[patent_app_date] => 2021-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 78175
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17216303
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/216303 | MATERIALS AND METHODS FOR TREATMENT OF AUTOSOMAL DOMINANT CONE-ROD DYSTROPHY | Mar 28, 2021 | Abandoned |
Array
(
[id] => 19021252
[patent_doc_number] => 20240077423
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-07
[patent_title] => A TRANSCRIPTIONAL REGULATOR SPECIFICALLY RESPONDING TO D-2-HYDROXYGLUTARATE AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/795351
[patent_app_country] => US
[patent_app_date] => 2021-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5709
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17795351
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/795351 | A TRANSCRIPTIONAL REGULATOR SPECIFICALLY RESPONDING TO D-2-HYDROXYGLUTARATE AND APPLICATION THEREOF | Mar 20, 2021 | Pending |
Array
(
[id] => 18374455
[patent_doc_number] => 20230149534
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-18
[patent_title] => HAPTENIZED CORONAVIRUS SPIKE PROTEINS
[patent_app_type] => utility
[patent_app_number] => 17/906784
[patent_app_country] => US
[patent_app_date] => 2021-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10228
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17906784
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/906784 | HAPTENIZED CORONAVIRUS SPIKE PROTEINS | Mar 18, 2021 | Abandoned |
Array
(
[id] => 18434425
[patent_doc_number] => 20230181719
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => NGR CONJUGATES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/912765
[patent_app_country] => US
[patent_app_date] => 2021-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20657
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17912765
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/912765 | NGR CONJUGATES AND USES THEREOF | Mar 18, 2021 | Pending |
Array
(
[id] => 17080682
[patent_doc_number] => 20210275688
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-09
[patent_title] => METHODS AND COMPOSITIONS FOR INHIBITING OXIDATIVE STRESS
[patent_app_type] => utility
[patent_app_number] => 17/206212
[patent_app_country] => US
[patent_app_date] => 2021-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26681
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17206212
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/206212 | Methods and compositions for inhibiting oxidative stress | Mar 18, 2021 | Issued |
Array
(
[id] => 18434342
[patent_doc_number] => 20230181636
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => ANTIBODY GENE EDITING IN B LYMPHOCYTES AND CO-EXPRESSION OF CARGO PROTEIN
[patent_app_type] => utility
[patent_app_number] => 17/906469
[patent_app_country] => US
[patent_app_date] => 2021-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19042
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 204
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17906469
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/906469 | ANTIBODY GENE EDITING IN B LYMPHOCYTES AND CO-EXPRESSION OF CARGO PROTEIN | Mar 17, 2021 | Pending |
Array
(
[id] => 17200471
[patent_doc_number] => 20210340566
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-04
[patent_title] => COMPOSITIONS AND METHODS FOR DIFFERENTIAL CAS9 GENE LABELING AND/OR EDITING
[patent_app_type] => utility
[patent_app_number] => 17/200398
[patent_app_country] => US
[patent_app_date] => 2021-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23201
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17200398
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/200398 | Compositions and methods for differential Cas9 gene labeling and/or editing | Mar 11, 2021 | Issued |
Array
(
[id] => 18769470
[patent_doc_number] => 20230364234
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-16
[patent_title] => COMPOSITIONS AND METHODS FOR CHIMERIC ANTIGEN RECEPTOR (CAR)-MODIFIED CELL MODULATION
[patent_app_type] => utility
[patent_app_number] => 17/905323
[patent_app_country] => US
[patent_app_date] => 2021-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15026
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17905323
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/905323 | COMPOSITIONS AND METHODS FOR CHIMERIC ANTIGEN RECEPTOR (CAR)-MODIFIED CELL MODULATION | Mar 7, 2021 | Pending |
Array
(
[id] => 18325914
[patent_doc_number] => 20230124042
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-20
[patent_title] => VACCINE AGAINST AFRICAN SWINE FEVER VIRUS INFECTION
[patent_app_type] => utility
[patent_app_number] => 17/905492
[patent_app_country] => US
[patent_app_date] => 2021-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17096
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17905492
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/905492 | VACCINE AGAINST AFRICAN SWINE FEVER VIRUS INFECTION | Mar 4, 2021 | Pending |
Array
(
[id] => 19280060
[patent_doc_number] => 20240216533
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-04
[patent_title] => HERPES SIMPLEX VIRUS AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/909173
[patent_app_country] => US
[patent_app_date] => 2021-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14889
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17909173
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/909173 | HERPES SIMPLEX VIRUS AND USE THEREOF | Mar 3, 2021 | Pending |
Array
(
[id] => 17214900
[patent_doc_number] => 20210348237
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-11
[patent_title] => METHODS AND COMPOSITIONS FOR AIDING IN THE DETECTION OF LUNG CANCER
[patent_app_type] => utility
[patent_app_number] => 17/182142
[patent_app_country] => US
[patent_app_date] => 2021-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16661
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17182142
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/182142 | METHODS AND COMPOSITIONS FOR AIDING IN THE DETECTION OF LUNG CANCER | Feb 21, 2021 | Abandoned |
Array
(
[id] => 16885717
[patent_doc_number] => 20210171912
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-10
[patent_title] => METHOD FOR SCALABLE SKELETAL MUSCLE LINEAGE SPECIFICATION AND CULTIVATION
[patent_app_type] => utility
[patent_app_number] => 17/175324
[patent_app_country] => US
[patent_app_date] => 2021-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8579
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17175324
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/175324 | METHOD FOR SCALABLE SKELETAL MUSCLE LINEAGE SPECIFICATION AND CULTIVATION | Feb 11, 2021 | Abandoned |
Array
(
[id] => 18239196
[patent_doc_number] => 20230071507
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => MACROPHAGE-DERIVED ENGINEERED VESICLES FOR TARGETED DELIVERY AND TREATMENT
[patent_app_type] => utility
[patent_app_number] => 17/799082
[patent_app_country] => US
[patent_app_date] => 2021-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20301
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17799082
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/799082 | MACROPHAGE-DERIVED ENGINEERED VESICLES FOR TARGETED DELIVERY AND TREATMENT | Feb 10, 2021 | Pending |
Array
(
[id] => 18252500
[patent_doc_number] => 20230079539
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => METHODS FOR RAPID CLONING AND EXPRESSION OF HLA CLASS I CELLS
[patent_app_type] => utility
[patent_app_number] => 17/929013
[patent_app_country] => US
[patent_app_date] => 2021-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9758
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -70
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17929013
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/929013 | METHODS FOR RAPID CLONING AND EXPRESSION OF HLA CLASS I CELLS | Feb 9, 2021 | Pending |
Array
(
[id] => 18299240
[patent_doc_number] => 20230108926
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => COMPOSITION AND METHOD OF mRNA VACCINES AGAINST NOVEL CORONAVIRUS INFECTION
[patent_app_type] => utility
[patent_app_number] => 17/798051
[patent_app_country] => US
[patent_app_date] => 2021-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7173
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17798051
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/798051 | COMPOSITION AND METHOD OF mRNA VACCINES AGAINST NOVEL CORONAVIRUS INFECTION | Feb 7, 2021 | Abandoned |
Array
(
[id] => 16963192
[patent_doc_number] => 20210214691
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => Delta133P53Beta and Delta133P53Gamma Isoforms Are Biomarkers of Cancer Stem Cells
[patent_app_type] => utility
[patent_app_number] => 17/166004
[patent_app_country] => US
[patent_app_date] => 2021-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22943
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17166004
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/166004 | Delta133P53Beta and Delta133P53Gamma isoforms are biomarkers of cancer stem cells | Feb 2, 2021 | Issued |
Array
(
[id] => 18278670
[patent_doc_number] => 20230094142
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => METHODS OF DIAGNOSING AND CLASSIFYING VIRAL INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 17/796284
[patent_app_country] => US
[patent_app_date] => 2021-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38133
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17796284
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/796284 | METHODS OF DIAGNOSING AND CLASSIFYING VIRAL INFECTIONS | Jan 28, 2021 | Pending |
Array
(
[id] => 18251291
[patent_doc_number] => 20230078330
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => HUMAN ANTI-DENGUE ANTIBODIES AND METHODS OF USE THEREFOR
[patent_app_type] => utility
[patent_app_number] => 17/759479
[patent_app_country] => US
[patent_app_date] => 2021-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42031
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -88
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17759479
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/759479 | HUMAN ANTI-DENGUE ANTIBODIES AND METHODS OF USE THEREFOR | Jan 18, 2021 | Pending |